In addition, derivative 1d was found to be a novel potent selective inhibitor of protein tyrosine phosphatase 1B (PTP1B, IC50 = 8.96 μM), a potential target for treating type II diabetes and obesity [11]. The gene discussed is PTPN1; the disease is obesity disorder.